Chiara Listorti

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Emad Aly

University of Aberdeen

UNITED KINGDOM

View details

Gabriele Martelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Luigi Mariani

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Corrado Tinterri

Extraordinary Professor

Humanitas University

ITALY

View details

Helena Salvador Roses

Associate Professor

University of Lleida

SPAIN

View details

Fady Yanni

Nottingham University Hospitals NHS Trust

UNITED KINGDOM

View details

Dennis Ho-Yin Lui

University College London

UNITED KINGDOM

View details

Margarida Ferreira

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

Paola Collini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chiara Listorti

Research Interests

Explore related searches

Contact this professor

Articles (12)

Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization

Non-palpable breast lesions localization techniques - A new priority: Results of a Senonetwork survey among breast centers in Italy

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis

Occurrence of breast-cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial

Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study

Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

Evaluation of appendicitis risk prediction models in adults with suspected appendicitis

Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer

High consistency between characteristics of primary intraductal breast cancer and subtype of subsequent ipsilateral invasive cancer

Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen

Selective axillary dissection after axillary reverse mapping in node positive breast cancer patients to prevent breast cancer related lymphedema. The issue of safety

Sentinel Node Mapping at the Time of COVID-19 Outbreak

Collaborators (9)

Emad Aly

Gabriele Martelli

Luigi Mariani

Corrado Tinterri

Helena Salvador Roses

Fady Yanni

Dennis Ho-Yin Lui

Margarida Ferreira

Paola Collini

Make your next move.